UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES AND EXCHANGE ACT OF 1934
(Date of earliest event reported):

August 17, 2012

Cardigant Medical Inc.
(Exact name of Registrant as specified in its charter)

Delaware, 333-176329, 26-4731758
(State or other jurisdiction
of incorporation) (Commission
File Number) (IRS Employer
Identification)

1500 Rosecrans Avenue, St 500
Manhattan Beach, CA 90266
(Address of principal executive office and zip code)

(310) 421-8654
(Registrant's telephone number, including area code)

Check the appropriate box bellow if the 8-K filing is intended to
simultaneously satisfy the filing obligations of the registrant under
any of the following provisions:

Written communication pursuant to Rule 425 under the Securities Act (17
CFR 230.425)


Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)


Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))


Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c)).


ITEM 5.02DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF
DIRECTORS; APPOINTMENT OF PRINCIPAL OFFICERS

Scott Merz, Ph.D. has been appointed to the board of directors. Dr. Merz
has extensive experience in all aspects of the medtech industry over the
last 25 years including technology startup, research and development,
regulatory, fundraising and partnering. Dr.Merz is currently the
President of Michigan Critical Care Consultants (MC3) of which he is
also a co-founder. MC3 was founded in 1991 to commercialize blood pump
technology developed by Dr. Merz. The technology was sold to Medtronic
and eventually transferred to Edwards Life Sciences. MC3 currently
incubates new technology and spins it out. MC3 has spun out six
companies based on internally developed technologies. Dr. Merz earned
his Bachelors Degree in Electrical/Biomedical Engineering from Duke
University and his Ph.D. in Biomedical Engineering from the University
of Michigan.

SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.

Cardigant Medical Inc.
By: /s/ Jerett Creed
Jerett Creed
Title: President and CEO

Dated: August 17, 201